CLINICAL_TRIALS
trial_result
· 2022-07-20
Clinical Trial Update: NOrth American Study for the Treatment of Recurrent epIstaxis With DoxycycLine: The NOSTRIL Trial [Phase 4]
Summary
Phase 4 trial update on doxycycline for recurrent epistaxis (NOSTRIL trial) completed with results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, Los Angeles | Conditions: Epistaxis | Phase 4 | Status: COMPLETED | Results posted: 2022-07-20